Ironwood Pharmaceuticals, Inc. - Class A Common Stock (NQ:IRWD)

3.809 +0.179 (+4.93%)

Delayed Quote Updated: 2:50 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ironwood Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

5 Value Stocks In The Healthcare Sector ↗

July 18, 2022

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...

Via Benzinga

The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine ↗

May 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Ironwood Presents New Data Demonstrating Potential of IW-3300 for Visceral Pain at Digestive Disease Week® (DDW) 2022

May 25, 2022

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Earnings Scheduled For February 17, 2022 ↗

February 17, 2022

Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.

Via Benzinga

Ironwood Pharmaceuticals to Present New IW-3300 and Linaclotide Data at Digestive Disease Week® 2022

May 09, 2022

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals: Q1 Earnings Insights ↗

May 05, 2022

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Ironwood Pharmaceuticals Reports First Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance

May 05, 2022

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals Q1 2022 Earnings Conference Call On May 5, 2022 At 08:30 AM ET ↗

April 29, 2022

Ironwood Pharmaceuticals (NASDAQ:IRWD) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 22, 2022 ↗

April 22, 2022

Upgrades

Via Benzinga

Ironwood Pharmaceuticals to Host First Quarter 2022 Investor Update Call

April 21, 2022

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

5 Value Stocks To Watch In The Healthcare Sector ↗

April 18, 2022

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

Jefferies Raises Price Target On This Small-Cap 'Stand Out' Biotech Stock ↗

March 02, 2022

Ardelyx Inc (NASDAQ: ARDX) shares are trading higher after Jefferies upgraded shares to Buy from Hold and raised the price target on the stock to $5 from $1. Analyst...

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

February 28, 2022

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples...

Via Benzinga

Ironwood Pharmaceuticals Earnings Perspective: Return On Capital Employed ↗

February 18, 2022

According to Benzinga Pro data Ironwood Pharmaceuticals (NASDAQ:IRWD) posted a 25.91% decrease in earnings from Q3. Sales, however, increased by 12.9% over the previous quarter to $117.13 million.

Via Benzinga

Ironwood Reports Mixed Q4 Results; Linzess Joins Blockbuster Club As US Sales Exceed $1B ↗

February 17, 2022

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) reported Q4 FY21 sales of $117.1 million, compared to $116.7 million in Q4 FY20, beating the consensus of $109.87 million....

Via Benzinga

The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios ↗

February 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...

Via Benzinga

Recap: Ironwood Pharmaceuticals Q4 Earnings ↗

February 17, 2022

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported its Q4 earnings results on Thursday, February 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; LINZESS® (linaclotide) Achieves Blockbuster Status as U.S. Net Sales Exceed $1 Billion in 2021

February 17, 2022

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Earnings Outlook For Ironwood Pharmaceuticals ↗

February 16, 2022

Ironwood Pharmaceuticals (NASDAQ:IRWD) is set to give its latest quarterly earnings report on Thursday, 2022-02-17. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More ↗

February 13, 2022

Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...

Via Benzinga

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Investor Update Call

February 03, 2022

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance

January 10, 2022

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 05, 2022

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals Appoints Sravan K. Emany as Chief Financial Officer

December 01, 2021

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Overview Of Value Stocks In The Healthcare Sector ↗

November 29, 2021

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

November 22, 2021

What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

After Flops, Ironwood Rebuilds It Pipeline With Liver Disease Deal ↗

November 04, 2021

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) has advanced plans to build its pipeline after securing a chance to license Cour Pharmaceuticals’ liver...

Via Benzinga

Ironwood Pharmaceuticals, inc (IRWD) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

IRWD earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Ironwood Pharmaceuticals Reports Third Quarter 2021 Results and Provides Corporate Development Update

November 04, 2021

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.